ANI Pharmaceuticals, Inc. (ANIP) NASDAQ
79.20
+3.97(+5.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
79.20
+3.97(+5.28%)
Currency In USD
| Previous Close | 75.23 |
| Open | 76 |
| Day High | 80.21 |
| Day Low | 76 |
| 52-Week High | 99.5 |
| 52-Week Low | 59.61 |
| Volume | 539,421 |
| Average Volume | 359,852 |
| Market Cap | 1.8B |
| PE | 20.26 |
| EPS | 3.91 |
| Moving Average 50 Days | 78.92 |
| Moving Average 200 Days | 83.63 |
| Change | 3.97 |
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET
GlobeNewswire Inc.
Feb 13, 2026 11:50 AM GMT
PRINCETON, N.J., Feb. 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its fourth quarter and full year 2025 financial results on Friday, February 27, 2026, pri
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
GlobeNewswire Inc.
Jan 12, 2026 11:50 AM GMT
For full year 2025, total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS expected to be within or above guidance ranges of $854 million to $873 million, $221 million to $228 million and $7.37 to $7.64, respectivelyRare Dise
ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 06, 2026 9:15 PM GMT
PRINCETON, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on